|
Published by: Euromonitor International
Published: Dec. 1, 2007 - 49 Pages
Table of Contents
- OTC HEALTHCARE IN FRANCE
- Executive Summary
- Slow Growth
- De-reimbursement Limited Impact
- Pharmacies Stronghold Lessening
- Changing Mentalities
- Potential Growth
- Key Trends and Developments
- OTC Products in Difficult Trading Conditions
- Demographic Trends Impact Demand
- De-reimbursement: Does It Work?
- Economic Growth Increases Visits To Private Doctors
- Hectic Lifestyles and Rising Health Awareness Drive Sales
- Market Indicators
- Table 1 Life Expectancy at Birth 2001-2006
- Market Data
- Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
- Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
- Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
- Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
- Table 6 Penetration of Private Label by Sector 2002-2006
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
- Appendix
- OTC Registration and Classification
- Advertising
- Packaging and Labelling
- Distribution
- De-listing Or De-reimbursement
- Vitamins and Dietary Supplements Registration and Classification
- Generics
- Consumer Expenditure on Health Goods and Medical Services
- Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
- Definitions
- Sources
- Summary 1 Research Sources
- LOCAL COMPANY PROFILES - FRANCE
- Arkopharma Sa, Laboratoires Pharmaceutiques
- Strategic Direction
- Key Facts
- Summary 2 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts
- Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators 2004-2006
- Company Background
- Production
- Competitive Positioning
- Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2006
- Beaufour-ipsen SA
- Strategic Direction
- Key Facts
- Summary 5 Beaufour-Ipsen SA: Key Facts
- Summary 6 Beaufour-Ipsen SA: Operational Indicators 2004-2006
- Company Background
- Production
- Summary 7 Beaufour-Ipsen SA: Production Statistics 2006
- Competitive Positioning
- Summary 8 Beaufour-Ipsen SA: Competitive Position 2006
- Juva Santé, Laboratoires
- Strategic Direction
- Key Facts
- Summary 9 Juva Santé, Laboratoires: Key Facts
- Summary 10 Juva Santé, Laboratoires: Operational Indicators 2004-2006
- Company Background
- Production
- Summary 11 Juva Santé, Laboratoires: Production Statistics 2006
- Competitive Positioning
- Summary 12 Juva Santé, Laboratoires: Competitive Position 2006
- Laboratoires Martin-johnson & Johnson-msd Sas
- Strategic Direction
- Key Facts
- Summary 13 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts
- Summary 14 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators 2004-2006
- Company Background
- Competitive Positioning
- Summary 15 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2006
- Pfizer Santé Grand Public
- Strategic Direction
- Key Facts
- Summary 16 Pfizer Santé Grand Public: Key Facts
- Summary 17 Pfizer Santé Grand Public: Operational Indicators 2004-2006
- Company Background
- Production
- Competitive Positioning
- Summary 18 Pfizer Santé Grand Public: Competitive Position 2006
- Pierre Fabre Sa, Laboratoires
- Strategic Direction
- Key Facts
- Summary 19 Pierre Fabre SA, Laboratoires: Key Facts
- Summary 20 Pierre Fabre SA, Laboratoires: Operational Indicators 2004-2006
- Company Background
- Production
- Summary 21 Pierre Fabre SA, Laboratoires: Production Statistics 2006
- Competitive Positioning
- Summary 22 Pierre Fabre SA, Laboratoires: Competitive Position 2006
- Théraplix SA
- Strategic Direction
- Key Facts
- Summary 23 Théraplix SA: Key Facts
- Summary 24 Théraplix SA: Operational Indicators 2004-2006
- Company Background
- Competitive Positioning
- Summary 25 Théraplix SA: Competitive Position 2006
- Upsa, Laboratoires
- Strategic Direction
- Key Facts
- Summary 26 UPSA Conseil SAS: Key Facts
- Summary 27 UPSA Conseil SAS: Operational Indicators 2004-2006
- Company Background
- Production
- Competitive Positioning
- Summary 28 UPSA, Laboratoires: Competitive Position 2006
- Urgo, Laboratoires
- Strategic Direction
- Key Facts
- Summary 29 Urgo, Laboratoires: Key Facts
- Summary 30 Urgo, Laboratoires: Operational Indicators 2004-2006
- Company Background
- Production
- Competitive Positioning
- Summary 31 Urgo, Laboratoires: Competitive Position 2006
- VITAMINS AND DIETARY SUPPLEMENTS IN FRANCE
- Headlines
- Trends
- Competitive Landscape
- Prospects
- Sector Data
- Table 12 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
- Table 13 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
- Table 14 Sales of Vitamins by Type: Value 2001-2006
- Table 15 Sales of Vitamins by Type: % Value Growth 2001-2006
- Table 16 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
- Table 17 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
- Table 18 Vitamins Brand Shares by Retail Value 2003-2006
- Table 19 Sales of Dietary Supplements by Type: Value 2001-2006
- Table 20 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
- Table 21 Dietary Supplements Brand Shares by Retail Value 2003-2006
- Table 22 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
- Table 23 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
AbstractEuromonitor International's Vitamins and Dietary Supplements in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.
Product coverage: vitamins, dietary supplements, tonics and bottled nutritive drinks, child-specific vitamins and dietary supplements
Data coverage: market sizes (historic and forecasts), company shares and brand shares.
Why buy this report?- Get a detailed picture of the vitamins and dietary supplements industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2008
|